Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JDQQ Formula
- Development stage
- Unknown
- Lead developer
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Administration
- Oral
01
Overview
JDQQ Formula (Jie Du Qing Qu Formula) is a Traditional Chinese Medicine (TCM) herbal formulation developed by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine and the Shanghai University of Traditional Chinese Medicine. Described as a detoxification and lung-clearing therapy, it is primarily investigated for its potential to improve survival benefits and clinical efficacy in patients with advanced non-small cell lung cancer (NSCLC). Specifically, it is being studied in patients with lung adenocarcinoma harboring EGFR-sensitive mutations who have developed resistance to tyrosine kinase inhibitors (TKIs). In clinical trials, the formula is typically administered orally in combination with standard Western medical regimens, such as platinum-based doublet chemotherapy with or without bevacizumab, to evaluate its role in enhancing therapeutic response and overcoming drug resistance.
- Other names
- Jie Du Qing Qu FormulaDetoxification and Lung-clearing FormulaJie Du Qing Qu Fang
Beyond the preview
Go deeper on JDQQ Formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JDQQ Formula.